EGFR and cancer: Moreover, miR-21 is positively regulated by EGFR signaling in cancer cells harboring activating EGFR mutations, and EGFR-TKIs can repress the aberrantly increased miR-21 levels, while miR-21 suppression could enhance EGFR TKIs therapeutic effects [203].